European Academy of Allergy and Clinical Immunology
A Written Declaration on Allergies has been tabled on October 21. In order to be adopted, the majority of the EU Parliament should vote for this by signing. The Written Declaration calls for the implementation of national programmes, better medical training and more scientific research to achieve a better management of the disease, in order to limit its evolution and cost to society.
The Scientific Communications Committee
 VP Communications and Membership Karin Hoffmann-Sommergruber |
|
 Website Editor Filippo Fassio |
 Newsfeed Editor Darío Antolín Amerígo |
 Social Media Editor Florin Dan Popescu |
About the Scientific Communications Committee:
The European Academy of Allergy and Clinical Immunology produces a broad portfolio of scientific content, position papers, guidelines and other formats for its members and the community. The adequate distribution of these contents has always been an essential aim of EAACI and became ever more important during the current global health emergency. The Scientific Communications Committee combines an enthusiastic team working on the optimal communication of scientific content created within the academy via the corporate and patient websites, social media channels and the EAACI newsletter.
Activities 2020
January 2020 – Brainstorming meeting with all editors and the EAACI headquarters team for marketing, science and communication (Reports, Updates, Creation of Standard Operating Procedures, Strategy for 2020)
April 2020 – Launch of the COVID-19 Resource Center combining scientific publications and documents from the EAACI Journals and expert groups
May 2020 – First edition of the digital newsletter
2020 – “Topic of the Month” activity was started, which involves EAACI social media channels, websites and newsletter
June 2020 – Election of Filippo Fassio as new Website Editor
July 2020: Membership survey on the communication strategy, content and channels used for the distribution of scientific and community/event information at EAACI.
January 2021: EAACI Newsfeed was launched and Darío Antolín Amerígo appointed as Newsfeed Editor
How to collaborate with the Scientific Communications Committee
You have been part of an EAACI project and have interesting reports/results for the EAACI community?Please don´t hesitate to contact us for support via science@eaaci.org
The Governance Committee
 Marek Jutel Committee Co- chair  Jurgen Schwarze Committee Co- chair  Ioana Agache Committee Co- chair |
Members |
Call for Meeting Chairs and Venue Proposals EAACI Food Allergy and Anaphylaxis Meeting (FAAM) 2022
EAACI would like to invite its members with an open call to submit proposals for Meeting Chairs and Venues for the EAACI Food Allergy and Anaphylaxis Meeting (FAAM) 2022 which shall take place in Autumn 2022, preferably in October. Deadline for submission is 25 November 2020, 23:59 CET. Please note that for any submission the EAACI Food Allergy Interest Group Chair has to be involved. More information can be found here.Click here to submit your proposal
This week celebrates European Antibiotic Awareness Day (EAAD), the annual European Union initiative to raise awareness of antimicrobial resistance as an increasing global public health threat and to promote the prudent use of antibiotics. To mark EAAD, EMA launched a social media campaign to highlight the importance of using antibiotics prudently. A set of info-cards focuses on what patients, healthcare professionals, veterinarians, health-leaders, journalists and the pharmaceutical industry in their respective roles can do on a daily basis to make sure that these important medicines are used wisely. Download the info cards here
The European Academy of Allergy and Clinical Immunology (EAACI) and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA), the two organisations coordinating the Secretariat of the European Parliament Interest Group on Allergy and Asthma, warmly welcome the European Commission's Beating Cancer Plan presented in February 2020. Coupled with the Horizon Europe EU Mission for cancer research, the initiatives provide a well-developed framework to address the challenges posed by cancer in the EU.
As one of the leading causes of mortality globally and the second cause of premature death from non-communicable diseases (representing 26% of the total number of deaths in the EU in 2016), cancer is undoubtedly one of the biggest health challenges of our times, next to cardiovascular and respiratory diseases.
We applaud the ambitious scope of the Beating Cancer Plan, encompassing prevention, access to care and better quality of life; while supporting a health-in-all-policies approach with an emphasis on tackling the environmental determinants of cancer. Actions under this framework have the potential to add value to other non-communicable disease areas such as allergy and asthma , which also impose a massive burden on Europeans' lives and pockets.
Indeed, allergy and asthma are two of the most common chronic diseases in Europe, currently affecting more than 150 million citizens across the region. Healthy environments play a crucial role in the prevention and control of these diseases, which are predicted to affect half of all Europeans by 2025.
Our statement lays out the multiple correlations existing between cancer, on the one hand, and allergy and asthma on the other . Shared risk factors include air pollution, tobacco smoking and exposure to dangerous chemicals, which may impact the severity or incidence of allergy and asthma symptoms. Furthermore, it discusses the need for improved access to healthcare, including timely diagnosis, in a wide range of non-communicable diseases in addition to cancer. Also highlighted are the benefits of patients' and healthcare professionals' participation in health decision-making processes, including research and evidence-based policies.
The statement is underpinned by the hope that the focus of Europe's Beating Cancer Plan on the guiding principles of prevention, access, and participation , will set a useful precedent for addressing other burdensome non-communicable diseases, including allergy and asthma.
Please click here to access the full statement
The EAACI NAS-JMs have translated two important EAACI position papers in your language! You can find the translations to Albanian, Bulgarian, Czech, Greek, Hungarian, Georgian, Romanian, Spanish, Turkish and Italian on our Media Library.
Brockow et al
??http://ow.ly/HPJa50AWdIU
Atanaskovic-Markovic et al
?? http://ow.ly/dPni50AWdIW
Brockow et al
??http://ow.ly/HPJa50AWdIU
Atanaskovic-Markovic et al
?? http://ow.ly/dPni50AWdIW
The EAACI Digital Congress 2020 is now over but most of the Congress scientific content is still available (for registered delegates) on the EAACI Digital Congress 2020 platform (virtual.eaaci.org) for a period of 6 months after the Congress. For all of those who were not registered, the content is also available in the form of thematic packages, to be purchased on the EAACI Media Library eShop. You can have access to our selection of packages now and purchase the one that fits you best!
The European Parliament adopted on Friday a resolution highlighting the need for a better management of chronic diseases. The adopted text is available at https://www.europarl.europa.eu/doceo/document/TA-9-2020-0205_EN.html.
Several milestones were achieved following the combined lobbying efforts:
2. European reference networks for chronic diseases
3. Recognition of the high prevalence of chronic diseases and need for action
4. Prioritisation of prevention
5. Implementation of “health in all policies”
6. Stronger role for the EMA in monitoring and managing drug shortages
7. Call for a European Health Union
Ioana Agache, on behalf of the ExCom EU lobbying group
The EAACI community is united in disseminating new research and knowledge on COVID-19. Find some of the most useful related content on our dedicated webpage, to better serve you and your patients. More resources on COVID-19 will be added as they are released by our community of experts (last update 28.10.2020).
The European Parliament Interest Group on Allergy and Asthma convened its first meeting of the 2019-2024 legislature on 20 November 2019, laying out the route to policy successes in Europe for allergy and asthma research, prevention and quality management.
Hosted by Members of the European Parliament (MEPs) Sirpa Pietikäinen and Cristian-Silviu Bușoi, leading Interest Group members, the meeting explored policy improvements to address two of the most prevalent chronic diseases, which affect one in three Europeans and represent an ever-growing burden on societies and healthcare systems.
Allergic diseases and asthma prevention as a priority for the incoming Commission: Wojciech Kalamarz (European Commission DG SANTE) highlighted that chronic diseases’ prevention will be a priority of the Von der Leyen Commission and called on Member States to increase investment in prevention, noting the cost-effectiveness of preventive measures.
Taking action across sectors building on the “exposome” concept: Prof Ioana Agache (Past-President, European Academy of Allergy and Clinical Immunology (EAACI)) advocated for policies looking at the interconnections between human, animal and plant health, and food and water safety to improve prevention in the field of allergy and asthma, which are essentially multifactorial diseases stemming mainly from biological responses to a variety of environmental triggers and less from individual-genetic factors.
Improving allergen labelling to better protect patients: Salvatore D’Acunto (European Commission DG GROW) noted the importance of fragrance allergens labelling for patients. He stated that the Commission is exploring different on- and off-product labelling options, and invited stakeholders to respond to the ongoing public consultation on fragrance labelling.
Interconnecting the health, air quality and climate change agendas came across as a key message from representatives of the WHO European Centre for Environment and Health, the European Environmental Bureau and EAACI. The EU Green Deal has the potential to deliver important steps in this direction, by allowing a cross sectoral approach to air pollution, investment in sustainable agriculture and green financing – with the promise of considerable benefits to the health of future generations. Prof Stefano del Giacco (EAACI Vice-President Education and Speciality) underlined the importance of efficient city planning to reduce risks associated with exposures, as well as registries, machine-learning, and integrated surveillance networks to monitor air quality as tools to provide independent evidence and data support for science-based policy-making. MEP Karima Delli, Chair of the European Parliament TRAN committee, reaffirmed her commitment to reducing emissions from the transport sector, linked with many chronic diseases including allergy and asthma.
A joint call for increased research funding and accelerated uptake of personalised medicine: Reflecting on MEP Dr Cristian-Silviu Bușoi’s perspectives, Dr Amalia-Irina Vlad (European Commission DG RTD) encouraged the allergy and asthma community to seize the opportunity of an enhanced Horizon Europe budget for research and innovation. Prof Vera Mahler (Paul-Ehrlich-Institut) noted that research should address the existing knowledge gap between biomarkers and clinical outcomes so that new treatments and products can be authorised. EAACI President Prof Marek Jutel highlighted the central role of implementing translational research and real world evidence to foster the integration of patient-oriented and population-based studies. Mikaela Odemyr, President of the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), called for universal patient access to personalised medicine which requires a reorientation of healthcare systems, with a focus on individual patients’ needs.
“We need better national programmes and their implementation, early action to protect our biodiversity and improved urban environments to prevent allergies and asthma. We need European Allergy and Asthma reference centre, we need more efforts to improve urban air quality and indoor air quality, we need better information about chemicals in our daily environment and food ingredients. We need to enter a new era where no one suffers from allergy and asthma.” – MEP Sirpa Pietikäinen.
Further insights from the event are available here.
The 2nd Pediatric Allergy and Asthma Meeting, PAAM 2011, will be held in the wonderful city of Barcelona, Spain, 13 – 15 October 2011, and will be attended by internationally renowned speakers from around the world. The scientific programme addresses not only specialists in pediatric allergology, but...
Read more
Read more
PhARF is a collaboration between Uppsala University and Phadia AB. It is based on an international Scientific Committee comprised of internationally recognized scientists in the field of allergy. The committee meets once a year to select candidates for the Award. Now is the time to nominate to the PhARF Award 2011. The deadline for Nomination is December 31st, 2010. The Award amounts to USD 50.000.
Read more
Read more
The European Academy for Allergy and Clinical Immunology (EAACI) has grown to become a very important medical association in Europe. We are proud that our community of medical professionals includes about 7’000 clinicians, academics and researchers.
Read more
Read more
Sections and Interest Groups (IGs) are at the heart of all EAACI activities and therefore of utmost importance for our organisation. If you are a Section or IG member, you have the unique opportunity to influence
the future of the Academy by participating in the 2013 elections. Vote for your Section and/or Interest Group Board Members and make a difference!
the future of the Academy by participating in the 2013 elections. Vote for your Section and/or Interest Group Board Members and make a difference!
Do not miss the chance to follow the EAACI Congress 2012 political symposium with the title: “EU Health Priorities: Political and Research Agenda” (Monday 10:45 - 12:15) live by clicking here.
There are only a few days left to submit your abstract for the next EAACI Winter School to be held in Are, Sweden, 12-15 February 2012. Follow the link below and grab the opportunity to submit your abstract no later than 15 November 2011!
Click here
Click here
PhARF (Phadia Allergy Research Forum) was established in 1987 to honor the 20th anniversary of the discovery of IgE at Uppsala University. PhARF is sponsored by Phadia, the world-leading company in the field of in vitro allergy diagnostics. The winner will be revealed at the Award Ceremony on Sunday 17 June during the EAACI Congress in Geneva Palexpo, Hall 2.
Read more
Read more
The Allergopharma Award was first established in 2000 on the initiative of Allergopharma Joachim Ganzer KG and in collaboration with EAACI. It is intended that the Award should recognize scientific achievement on the part of younger members of the EAACI in the field of allergy and encourage their engagement in further research. Applications for the Award are therefore restricted to members or affiliates of the EAACI, under the age of 40 years, who have conducted their research in a European centre. Follow the link below and apply for this award!
Read more
Read more
It is with deep sadness that we announce the premature death of our dear colleague Professor Fabienne Rance. Professor Rance carved out a magnificent career in the field of pediatric allergy and in food allergy. She authored or co-authored more than 250 articles in medical journals and contributed with more than 50 chapters textbooks.
The JMA QuizzTM Series consist of a series of quiz, posted each month, in order to test the scientific knowledge along with other, EAACI-related information. The winners will be awarded with a Travel Grant for the 31st EAACI Annual Congress which will take place in Geneva, 16-20 June 2012. Do not miss the opportunity and participate on the quiz now!
Professor Andrzej Szczeklik, distinguished scientist, dedicated physician, active member of the EAACI and respected by all of us, died unexpectedly 3 February 2012 in Krakow, Poland, at the age of 73. After graduating from the University of Krakow and carrying out his internship in the USA, Professor Andrzej Szczeklik...
Read more
Read more
Adverse drug reactions (ADRs) have been reported to account for 3 to 6% of all hospital admissions and occur in 10 to 15% of hospitalized patients. It is a response to a drug that is noxious and unintended and occurs at doses normally used in man. Drug reactions can be considered as being either predictable or unpredictable. Follow the link below in order to read the whole paper.
Read more
Read more
EAACI Allergy Schools are again in the front line of summer's attention travelling to Estonia, Austria and Spain! The registration is already open for Estonia & Austria until 15 July and 1 August respectively, through a brand new online registration tool. Also, abstract submission period is opening on the 20 June 2012, so do not miss the opportunity to attend and read through all the respective dates/deadlines by clicking here.
The Executive Committee is the major administrative committee of the EAACI. It comprises of the President, the Secretary General, the Treasurer, the Past President, the three Vice-Presidents, six Members-at-Large, and the Chairpersons of the five EAACI Sections. Α new Executive Committee has now been ratified by the General Assembly held on Monday 14 June in the context of the annual Congress in Istanbul. In order to view the members of the new EAACI Executive Committee, click below.
Read more
Read more
The EAACI Dermatology Section organizes a unique learning opportunity aiming at exchanging experience among young clinicians and researchers in the field of allergy. This new initiative will be held in Zurich, Switzerland from 24 to 25 March 2012 at the University Hospital. Click here to view all the details online.
This month's profile is coming from Prof. Claus Bachert, who answers questions about his career in the field of allergy, his experience with the EAACI and much more. Follow the link below to read the entire interview.
Read more
Read more
The EAACI Pediatric Allergy and Asthma Meeting was successfully held in Barcelona, 13-15 October, and was attended by physicians and scientists from all around the world. For those of you who missed the opportunity to participate, click here to view the Press Releases from PAAM 2011.
EAACI-GA2LEN offered once again a high-level education by experts in the field of Allergy. The 5th EAACI-GA2LEN Allergy School which took place in Athens, Greece on the 25th - 28th of June 2010 has finished. This year's theme was "Allergy in Different Systems 2010". Any attendant had the opportunity to interact with world experts, pioneers in the field of Allergy and go deep into the systemic nature of allergic diseases. Click here to read the most of the educational material!
Registration for the EAACI Drug Hypersensitivity Meeting 2014 is open.
The Drug Hypersensitivity Meeting (6th edition: Bern, Switzerland, 9–12 April 2014) gathers researchers and physicians from different disciplines to exchange their most up-to-date data in this continually evolving field and to transfer it to clinical practice.
The ICON on Drug Allergy is published! It was carried out by the leading allergy organizations worldwide (EAACI, AAAAI, ACAAI and WAO) to synthesize multiple guidelines into one generally approved and accepted consensus document.
The Secretary of the EAACI Ethics Committee, Prof. Jacques Gayraud, answers questions concerning his career path, as well as his involvement in EAACI activities.
Read more
Read more
The EAACI JMA Working Group and the European Rhinologic Society Junior Board are organising two exciting symposia specifically for JMAs! These will take place during the next ERAM-SERIN Congress in Brussels, 4th to 6th November 2010. The symposia focus on the basic and clinical aspects of inflammatory diseases of the upper and lower airways.
Read more
Read more
Junior and senior scientists met in one of the most beautiful islands of Europe fo a successful blend of scientific and social interaction. The EAACI & GA2LEN Allergy School on Lifestyle interventions in Allergy & Asthma took place in Costa Rei, Italy, 9th to 12th September 2010, with the support of the Italian Association of Allergists and Immunologists in collaboration with the EAACI Asthma Section and the EAACI Allergy, Asthma & Sports Interest Group. For those who did not have the chance to attend, the report from AS in Sardinia is now available online!
Read more
Read more
EAACI Awards include the Clinical Research Award, the Improving Treatment and Prevention of Allergic Diseases Award, the Experimental Research in Allergy/Clinical Immunology Award, the Promotion of Allergy at the Specialty in Europe Award and many more! The winners of these EAACI Awards are announced yearly during the Annual Congress. Click here to see the Winners of the 2010 Medal Awards!
Read more
Read more
www.eaaci.net launches a new section including a collection of copies of media content appearing on other publications and focusing on the activities of our Academy. View our new category here and read the first media clippings added online.
The 30th EAACI Congress in Istanbul commenced on Saturday 11 June 2011 with almost 8,000 registered participants from all over the world and a panel of 464 speakers. The congress opened with an Opening Ceremony during which EAACI President Prof. Jan Lotvall presented the EAACI Noon Award, one of the initiatives developed by the Academy to celebrate 100 years of Immunotherapy. To read the full report, please follow the link below.
Read more
Read more
EAACI-GA2LEN Allergy Schools offer this year a journey which starts from Greece, goes to Lithuania, then moves down to Sardinia, goes to Turkey and terminates in Germany. All of these schools guarantee you an experience to excellence education while its purpose is to stimulate the social contacts between young people interested in allergy and clinical immunology. These courses are arranged in collaboration with the EAACI National Membership Society of the host country of each school. It's a great opportunity to build on your education and expand your professional
Read more
Read more
The international PhD and MD/PhD Program Inflammation and Immunity (IAI) announces new openings for graduate student positions awarded to the best candidates on a competitive basis. Graduate students admitted to the IAI PhD program will have a regular employment with full social security coverage at the Medical University of Vienna and receive funding for at least 3 years according to the salary scheme of the Austrian Science Fund (FWF). The deadline for submitting your application is the 15th of September 2010. Thus, do not waste time! EAACI has published all the necessary documents for this job offer, application guidelines, application forms and applicant's evaluation forms. Grab the opportunity and submit your job application form now!
Read more
Read more
EAACI Focused Meetings provide you with the opportunity of in-depth understanding of specific topics and discussions within targeted medical communities. The next EAACI Focused Meeting is Food Allergy and Anaphylaxis Meeting, FAAM 2011, which will take place in Venice, Italy, 17 - 19 February 2011. 50 Travel Grants, worth of 300 Euros each, have been allocated to EAACI Junior and Affiliate Junior Members who are presenting an abstract at this Meeting. Click here to find out more about it.
Webcasts are an interactive e-learning application combining sound, image, and script. New series have been produced from FAAM 2011 and is now online, accessible to all eaaci.net visitors. Seize the opportunity and expand your knowledge with a unique educational experience. Follow the link below to view these webcasts in flash format.
It is our pleasure to inform you that the EAACI Drug Hypersensitivity Meeting website is now open and we invite you to visit the www.eaaci-dhm2012.com for more information! The Meeting will be the prime event of the year in the area of drug hypersensitivity. It is aimed to give up to date information for clinicians and researchers and will cover basic, translational...
Read more
Read more
The JMA WG takes the initiative now to ask all JMAs for their opinions about EAACI-related issues to build an understanding of JMA preferences. Take part in this online questionnaire and give us your feedback! All JMAs should also take the opportunity to test their scientific knowledge and participate in the JMA Quiz now! Winners will be awarded a Travel Grant.
Read more
Read more
The EAACI Hymenoptera Venom Allergy School will take place on 11 - 13 April 2013 in Munich, Germany.
It will provide attendees with an update on specific diagnosis of insect venom allergy, basic immunology of allergy and mechanisms of specific immunotherapy, and more.
You can find additional information and register here.
It will provide attendees with an update on specific diagnosis of insect venom allergy, basic immunology of allergy and mechanisms of specific immunotherapy, and more.
You can find additional information and register here.
New webcast series have been produced from the recent EAACI's Annual Congress in Istanbul 2011 and is online, accessible to all EAACI members. Expand your knowledge with a unique educational experience by following the link below to view in flash format.
Read more
Read more
"You might already have heard that a group of enthusiasts recently formed an Epidemiology IG within the EAACI, and you might have asked yourself what the additional role of such a group within the EAACI could be, given that most of the Sections and IGs already cover epidemiology and clinical research within their own specialist areas." . Click here to read the entire editorial.
Drugs are both used to treat urticaria and may be a cause of urticaria. Good information on incidence of drug-induced urticaria is hard to find. Urticaria is listed as a possible side effect of many drugs on the market. The best known are antibiotics and non-steroidal anti-inflammatories (NSAIDs) but even H1 antihistamines have been implicated as an occasional cause. Many drug reactions presenting with acute urticaria are due to type I hypersensitivity, involving the interaction of... Click here to read the whole Expert Opinion!
Read more
Read more
The opening date for the Pediatric Allergy & Asthma Meeting is only a few days away. Don't miss the opportunity to register now and participate to the PAAM 2011 meeting that will be held on 13-15 October 2011, Barcelona, Spain. For more information, click below to enter the official PAAM website.
Read more
Read more
The 10th EAACI-GA2LEN Winter School will take place from February 12 - 15, 2012 in Are, Sweden under the theme Basic Immunology Research in Allergy and Clinical Immunology. Do not miss the opportunity and register now following the link below.
Read more
Read more
Wiley-Blackwell launches a new online product delivery website, Wiley Online Library, which will replace the current website, Wiley InterScience. We invite you to implement and test journal access links that will be used to deliver journal access to the members and patrons from EAACI's website. All users will be redirected from Interscience to Wiley Online Library (WOL) although logins and passwords will stay the same. Join www.wileyonlinelibrary.com and enjoy the enhanced functionality that adds value to your research!
Read more
Read more
Each year, the EAACI offers a number of educational grants to help members in financial difficulty to cover the cost of their membership. All Individuals and Affiliate Members of the Academy are welcome to submit their application for this grant!
The 2nd Pediatric Allergy and Asthma Meeting, PAAM 2011, will be held in the wonderful city of Barcelona, Spain, 13 – 15 October 2011, and will be attended by internationally renowned speakers from around the world. The scientific programme addresses not only specialists in pediatric allergology, but...
Read more
Read more
The Edinburgh Allergy School on "Clinical Impact and Mechanisms of Infections in Allergy" and the Verona Allergy School on "Allergic Reaction to Drugs – From Bench to Bedside" have attracted numerous attendants and www.eaaci.net is proud to publish a number of advanced scientific presentations from these events online.
EAACI and GA2LEN continue offering outstanding educational opportunities through Allergy Schools this summer! You still have the chance to register for the Allergy School that will take place in Edinburgh, UK on 15-18 September 2011 in Edinburgh, UK under the theme "Clinical Impact and Mechanisms of Infections in Allergy". Seize the opportunity and register now!
Read more
Read more
The EAACI Interest Group on Aerobiology and Air Pollution is organizing a workshop to inform all stakeholders about ongoing and future developments in allergy research in Europe and to increase public awareness about this epidemic. Follow this link and view all related information and agenda online.
The EAACI Allergy School on "Dermatitis and Eczema" was held in Krakow, Poland on 18 - 21 August 2011 and www.eaaci.net is proud to publish a number of advanced scientific presentations from this event online.
Read more
Read more
Webcasts are an interactive e-learning application combining sound, image, and script. New series have been produced from the recent EAACI ERAM/SERIN and SAM and is now online, accessible to all eaaci.net visitors. Seize the opportunity and expand your knowledge with a unique educational experience. Follow the link below to view these webcasts in flash format.
Read more
Read more
The new edition of the highly regarded ABC of Asthma has been thoroughly revised with reference to the latest British Thoracic Society guidelines for asthma in children and adults. A short preview may be found here.
The EAACI Asthma Section has identified that the critically important missing link in their asthma portfolio is in the area of severe asthma and asthma exacerbations. They will address this by developing an EAACI Statement on Asthma Exacerbations and Severity and by organising a...
Read more
Read more
The new EAACI Thematic Month issue focuses on the Interest Group on Allergy, Asthma & Sports (IGAAS). Priority of IGAAS is the promotion of research on the prevalence, pathogenesis, diagnosis, and treatment of sports-related allergic diseases, including exercise-induced asthma, rhinitis, urticaria and anaphylaxis.
Read more
Read more
The EAACI Pediatric Allergy and Asthma Meeting in Barcelona, 13-15 October 2011, was a major success, and was attended by physicians and scientists from all around the world. All abstracts from this meeting are now available online by clicking here. You may also read all the related Press Releases following this link.
A Task Force on allergic disease registries was set up in late 2011 with the overall objective to provide a platform for the formation of allergic disease registries across EU country borders to develop suitable monitoring tools for use in both clinical practice and research.
Read more
Read more
PhARF (Phadia Allergy Research Forum) was established in 1987 to honor the 20th anniversary of the discovery of IgE at Uppsala University, the immunoglobulin that causes classic allergic diseases like asthma, hay fever, eczema and anaphylactic shock. PhARF is sponsored by Phadia, the world-leading company in the field of in vitro allergy diagnostics. The Scientific Committee of PhARF (consisting of the Presidents of EAACI, AAAAI and WAO) has now chosen 4 final candidates for the PhARF Award 2011. Who the winner is will be revealed at the Award Ceremony Monday 13 June at the EAACI congress in Istanbul.
Read more
Read more
As part of a Media partnership with Touch Briefings, EAACI members receive free eBook access to Touch Briefings ‘European Respiratory Disease’ Volume 7, Issue 2. European Respiratory Disease is a bi-annual peer-reviewed journal that includes review articles, case reports and many more.
Read more
Read more
Everything you always wanted to know about allergies is the philosophy behind the new EAACI portal. An allergy body guide, information on allergic conditions such as rhinitis, asthma and atopic dermatitis, updates on allergy vaccines, a list of major allergy precipitants and allergy assessment questionnaires are only a few of the resources available to the public through www.infoallergy.com.
Read more
Read more
We mourn the loss of our colleague and friend Dimitris Kalogeromitros, who passed away unexpectedly on Wednesday, 6 April 2011. Dimitris was a wonderful friend and a talented scientist, Head of Allergology at the Attikon Hospital of the University of Athens, where he established a model Allergy unit, for clinical care, research and training. He was also Guest Professor at the Allergy-Centre-Charite in Berlin...
Read more
Read more
The 2011 EAACI Allergy Schools held in Krakow, Edinburgh, and Verona have left indelibly worthwhile impressions on all the participants. Find out what it feels like to be part of our Schools by viewing pictures from these three Allergy Schools held the previous months by clicking the link below.
Read more
Read more
The presentation slides of the Allergy School on Specific Allergy and Immunotherapy which took place on 15-17 November in El Escorial, Spain are now online, available only for members. Login to the Members Area and access the presentations!
The International Severe Asthma Forum (ISAF) will take place on 11 - 13 October 2012 in Gothenburg, Sweden. More information will follow soon. Do not miss this event!
Read more
Read more
A new EAACI/GA2LEN Allergy School will take place on 29 March - 01 April 2012 in Davos, Switzerland! This year, the School is conducted under the theme "From Skin to Lung - From Theory to Patients". Visit our related webpage and read all the essential information.
EAACI is part of the HAE: Learn About It, Talk About It™ programme, a global healthcare professional-only programme aimed at improving the accurate diagnosis and appropriate management of patients with hereditary angioedema (HAE).
This month, the new Case Report is presented by Dr. Pavol Surda and his colleagues who are trying to solve a case report of the Castleman's Disease of the neck in a 13-year-old girl. Follow the link below to read the whole Case Report.
Read more
Read more
EAACI is happy to announce that the Clinical and Translational Allergy (CTA) online Journal has been tracked by PubMed since the last few weeks. This achievement allows substantial visibility and global access to all published papers. The most read publications in CTA are available here.
The Academy's Immunotherapy IG Board Members present their planned projects for the next two years and a number of interesting publications in the field. This resource is themed "100 years of allergen specific immunotherapy -- the future has just begun". Read the Thematic Month online.
This month’s new Case Report is presented by Ana Reis Ferreira, Carmen Botelho, and Josefina R. Cernadas. The Drug Allergy Interest Group Team describes an uncommon case of Non-Immediate Hypersensitivity Reactions to Multiple Antibiotics in a 2-year-old girl. The Case Report is DOI-registered, so feel free to cite it appropriately in your own work!
Read more
Read more
Take advantage of the early fee deadline and register for the forthcoming Drug Hypersensitivity Meeting (DHM) before 17 February 2012. The 2012 EAACI DHM will be held on 11-14 April, 2012 in Munich, Germany and you may submit your abstract by clicking here and find any related information online by visiting the www.eaaci-dhm2012.com. The Meeting will be the prime event of the year in the area of drug hypersensitivity.
Read more
Read more
Allergy today is a public health concern of pandemic proportions, affecting more than 150 million people in Europe only. Taking into account the epidemiological trends, the European Academy of Allergy and Clinical Immunology (EAACI) predicts that in less than 15 years more than half of the European population will suffer from some type of allergy. Allergic patients do not only suffer from a debilitating disease, with a major impact on their quality of life, career progression....
Read more
Read more
The EAACI Epidemiology Interest Group (IG) was launched at the Annual Congress in Istanbul, following approval by the Executive Committee. Follow this link and find out the aims and scopes of this newly formed Epidemiology IG.
The EAACI Infection & Allergy IG has organized a survey in order to trace influenza vaccination practices in the allergy community as well as the interest of its members for participation and promotion of related awareness campaigns. Actions organized by EAACI members will be presented in the forthcoming Summit of the European Scientific Working group on Influenza (ESWI).
Workers exposed to occupational sensitizers are at risk of developing occupational allergy. Asthma is the most frequently reported and compensated work-related respiratory disease in industrialised countries, and occupational exposures account for a substantial proportion of adult asthma incidence (1). Work-related asthma (WRA) refers to at least two nosological entities (2).
Read more
Read more
The European Academy of Allergy and Clinical Immunology - EAACI is one of the biggest medical associations in the World in the field of allergy, asthma and immunology. The continuation of this growth and success will be possible by a) Extensive and efficient communication of the science and novel developments in the field of allergy, asthma and immunology to the rest of the world by organization of beautiful annual meetings, focused meetings, schools; through our scientific journals, newsletter, website, press releases...
Read more
Read more
The third round of the Mentorship Programme designed to promote the ongoing education of young scientists and enhance the JMAs capacity as professionals is launched.
Would you like to be Mentored by a senior EAACI member? The call for Mentees is now open! Submit your applications by the 4 April, 2014."
Would you like to be Mentored by a senior EAACI member? The call for Mentees is now open! Submit your applications by the 4 April, 2014."
Access to the EAACI Ηandouts website is available to all EAACI members as of 1 October 2011. Use your login username and password and explore our wealth of educational resources brought to you by distinguished scientists. Enter the website now and read supporting material connected to the 2011 EAACI Annual Congress held in Istanbul by following the link below.
Read more
Read more
FAAM 2013 is just a few days away! This meeting, which will take place on 7-9 February in Nice, France, will address issues such as the onset of food allergy and trigger factors, current treatment of food allergy and much more. Join us now!
Go to FAAM 2013
Go to FAAM 2013
The 11th Allergopharma Award in the value of Euro 10,000 was first established in 2000 on the initiative of Allergopharma Joachim Ganzer KG and in collaboration with the EAACI. Therefore the Award is open to members of the EAACI, and in particular Junior Members, who have conducted their research in a European centre. Click here to find out usefull information about the applications.
Read more
Read more
Franz Marrache was born in Casablancea (Morocco) on December 7th - 1928 within the Jewish moroccan community. His origins will explain his qualities of welcoming, open-mindedness and also of fighting spirit. He was a bright pupil, as well in the field of literature as in philosophy or science.
Read more
Read more
Registration and abstract submission for the EAACI Allergy School on Investigating allergic effects of environmental exposures is now open.
Registration is also open for the Allergy School on Research Methods.
Read the Report on the recent and very successful 12th Winter Allergy School that took place in Poiana Brasov. Log in and take the opportunity to study the presentation slides from some of the leading speakers of this Allergy School.
Registration is also open for the Allergy School on Research Methods.
Read the Report on the recent and very successful 12th Winter Allergy School that took place in Poiana Brasov. Log in and take the opportunity to study the presentation slides from some of the leading speakers of this Allergy School.
This month, the new Case Report is presented by Dr. Livije Kalogjera and his colleagues who trying to solve a case describing the Granulomatous vasculitis in a 5-year old child. Click below to solve the case.
The 31st EAACI Annual Congress has started in a celebrating atmosphere in Geneva, Switzerland, on 16-20 June 2012, under the theme "At the Crossroads of Research, Practice and Education". Visit the Congress's website and read all the essential information here!
This month EAACI's Thematic Month Section focuses on Allergy Diagnosis. In modern allergy diagnosis, the responsiveness to allergen suggested by the clinical history of an allergic patient should be confirmed by an ex vivo or in vitro test. These laboratory tests are the realm of the Interest Group for Allergy Diagnosis (IGAD). The commonly used in vitro test is determination of specific IgE, whereas the ex vivo test may be histamine release or up regulation of surface molecules CD63 or CD203c on basophil granulocytes, known as the basophil activation test, BAT.
Read more
Read more
The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) organised in collaboration with EAACI an event at the European Parliament in Brussels on “May Contain/Contains – Food Allergen Labelling”.
Read more
Read more
This month, a new Case Report is presented by Gianni Pala, MD, on Occupational Rhinitis and Asthma. Gianni Pala along with his colleagues describe an uncommon case of occupational rhinitis and asthma due to Ephestia kuehniella in a cereal stocker. The Case Report is DOI registered so feel free to cite it appropriately in your own work!
Read more
Read more
Profile
Prof. J. Schwarze
Prof. J. Schwarze
This month, EAACI's Web Management Team interviewed the Secretary of the Infections and Allergy Interest Group, Prof. Jurgen Schwarze. Prof. Schwarze shares with us his experience as an EAACI member at first, and since 2009 as the secretary of this Interest Group. He answers questions concerning his specialty, gives advice to junior scientists, and comments on his field of research.
Read more
More than 75% of the asthma patient care costs are attributed to severe asthma cases.
Over 150 delegates from more than 30 countries met in Gothenburg, Sweden, at the International Severe Asthma Forum, ISAF, 2012. ISAF 2012 aims to respond to the need for a more rational approach to the treatment of severe asthma.
Read more
Over 150 delegates from more than 30 countries met in Gothenburg, Sweden, at the International Severe Asthma Forum, ISAF, 2012. ISAF 2012 aims to respond to the need for a more rational approach to the treatment of severe asthma.
Read more
You can now see the pictures of the EAACI International Severe Asthma Forum (ISAF) 2012, which took place in Gothenburg, Sweden, 11 - 13 October 2012. Click here and see photos of the sessions, poster and abstract presentations, and more!